Technology area: Biotechnology & Pharmaceuticals
10 pending office actions • 10 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
UNIVERSITEIT ANTWERPEN has 11 pending office actions in Biotechnology & Pharmaceuticals. The docket includes 11 distinct examiners and 10 distinct art units. Each matter has a distinct examiner, while the art-unit figure indicates that at least some prosecution is grouped within an art unit.
KOROMA, SORIE IBRAHIM is the busiest examiner, with 1 pending matter. The examiner distribution favors matter-specific prosecution management, while the art-unit grouping may support comparison of recurring eligibility, written-description, or prior-art issues when the underlying technologies overlap. Any shared response framework should preserve examiner-specific distinctions.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 1 (10%) |
| §112 only | 4 (40%) |
| Multi-statute (no §101) | 4 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOROMA, SORIE IBRAHIM | 1 | 50.0% | +0.0% |
| MCKOY, QUINCY ANDRE | 1 | 68.4% | +39.8% |
| JACKSON III, WALTER | 1 | 50.0% | +0.0% |
| CELSA, BENNETT M | 1 | 33.3% | +0.0% |
| RUMP, RICHARD M | 1 | 74.4% | +20.3% |
| TSUI, YUNG-SHENG M | 1 | 66.5% | +6.3% |
| DOLETSKI, BLAINE G | 1 | 75.1% | +9.0% |
| GRASER, JENNIFER E | 1 | 76.8% | +23.2% |
| O DELL, DAVID K | 1 | 57.7% | +36.0% |
| BORGEEST, CHRISTINA M | 1 | 55.7% | +21.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18552827 | Vaccine Compositions for Trypanosomatids | GRASER, JENNIFER E | 3d overdue |
| 18690996 | FEEDING SYSTEM FOR FEEDING POWDER MATERIAL AND SYSTEM FOR CONTINUOUS PRODUCTION OF SOLID DOSAGE FORMS | TSUI, YUNG-SHENG M | 75d |
| 18997177 | METHOD AND SYSTEM FOR PROCESSING A PLURALITY OF CAMERA IMAGES OF A HUMAN BODY TARGET AREA OVER TIME | KOROMA, SORIE IBRAHIM | — |
| 18718343 | METHOD FOR OBTAINING A NEUROMUSCULAR ORGANOID AND USE THEREOF | JACKSON III, WALTER | — |
| 18706868 | BIOBASED FERTILIZER COATINGS WITH NANOPARTICLES | CELSA, BENNETT M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18552827 | Vaccine Compositions for Trypanosomatids | GRASER, JENNIFER E | 3d overdue |
| 17627953 | MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION | BORGEEST, CHRISTINA M | 13d |
| 18276532 | QUINAZOLIN-4-ONE AND THIENO[2,3-D]PYRIMIDIN-4-ONE INHIBITORS OF ERBB4 (HER4) FOR USE IN THE TREATMENT OF CANCER | O DELL, DAVID K | 21d |
| 18871130 | DPP9 BINDING COMPOUNDS | MCKOY, QUINCY ANDRE | — |
| 18701078 | AMMONIUM NITRATE PRODUCTION | RUMP, RICHARD M | — |
| Art Unit | Apps |
|---|---|
| 2662 | 1 |
| 1626 | 1 |
| 1638 | 1 |
| 1600 | 1 |
| 1759 | 1 |
| 1684 | 1 |
| 1692 | 1 |
| 1645 | 1 |
| 1621 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18997177 | METHOD AND SYSTEM FOR PROCESSING A PLURALITY OF CAMERA IMAGES OF A HUMAN BODY TARGET AREA OVER TIME | KOROMA, SORIE IBRAHIM | 2662 | §101§103 | Non-Final OA | — | Pending | Jan 20, 2025 |
| 18871130 | DPP9 BINDING COMPOUNDS | MCKOY, QUINCY ANDRE | 1626 | §112 | Non-Final OA | — | Pending | Dec 02, 2024 |
| 18718343 | METHOD FOR OBTAINING A NEUROMUSCULAR ORGANOID AND USE THEREOF | JACKSON III, WALTER | 1638 | §103§112 | Non-Final OA | — | Pending | Jun 10, 2024 |
| 18706868 | BIOBASED FERTILIZER COATINGS WITH NANOPARTICLES | CELSA, BENNETT M | 1600 | §102§103§112Other | Non-Final OA | — | Pending | May 02, 2024 |
| 18701078 | AMMONIUM NITRATE PRODUCTION | RUMP, RICHARD M | 1759 | §112 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18690996 | FEEDING SYSTEM FOR FEEDING POWDER MATERIAL AND SYSTEM FOR CONTINUOUS PRODUCTION OF SOLID DOSAGE FORMS | TSUI, YUNG-SHENG M | 1684 | §102§112 | Non-Final OA | 75d | Pending | Mar 11, 2024 |
| 18578432 | TWO-STAGE CHEMICAL RECYCLING OF POLYURETHANES | DOLETSKI, BLAINE G | 1692 | §103 | Non-Final OA | — | Pending | Jan 11, 2024 |
| 18552827 | Vaccine Compositions for Trypanosomatids | GRASER, JENNIFER E | 1645 | §103§112 | Final Rejection | 3d overdue | Pending | Sep 27, 2023 |
| 18276532 | QUINAZOLIN-4-ONE AND THIENO[2,3-D]PYRIMIDIN-4-ONE INHIBITORS OF ERBB4 (HER4) FOR USE IN THE TREATMENT OF CANCER | O DELL, DAVID K | 1621 | §112 | Non-Final OA | 21d | Pending | Aug 09, 2023 |
| 17627953 | MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION | BORGEEST, CHRISTINA M | 1675 | §112 | Non-Final OA | 13d | Pending | Jan 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITEIT ANTWERPEN has 10 pending office actions as of October 2026, spread across 10 art units and 10 examiners.
Sorie Ibrahim Koroma has the most, with 1 of UNIVERSITEIT ANTWERPEN's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
